Literature DB >> 30004267

Gastroesophageal Reflux Disease in Obese Patients.

Antono C Valezi1, Fernando A M Herbella2, Francisco Schlottmann3,4, Marco G Patti3.   

Abstract

Gastroesophageal reflux disease (GERD) and obesity coexist in many patients in the Western population. The association is not coincidental, since GERD pathophysiology is, in part, linked to obesity. Visceral adipose tissue secretes hormones, which increase the risk of GERD. Obesity increases esophageal motor disorders and higher number of transient lower esophageal sphincter relaxations. Central obesity increases abdominal-thoracic pressure gradient and disrupts the gastroesophageal junction by inducing hiatal hernia formation. Obese patients benefit from weight loss by diet to decrease GERD symptoms; however, Roux-en-Y gastric bypass surgery is associated with a higher weight loss and a decrease in GERD symptoms, and is considered the best way to treat both diseases at the same time.

Entities:  

Keywords:  gastroesophageal reflux disease; obesity; pathophysiology

Mesh:

Year:  2018        PMID: 30004267     DOI: 10.1089/lap.2018.0395

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  3 in total

1.  The Role of the Transdiaphragmatic Pressure Gradient (TGP) in the Pathophysiology of Proximal Reflux.

Authors:  Leonardo de Mello Del Grande; F A M Herbella; M G Patti
Journal:  J Gastrointest Surg       Date:  2021-01-14       Impact factor: 3.452

2.  Prevalence of gastroesophageal reflux disease: a population-based cross-sectional study in southern Chile.

Authors:  Carlos Manterola; Luis Grande; Luis Bustos; Tamara Otzen
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-02-19

3.  Augmented CPT1A Expression Is Associated with Proliferation and Colony Formation during Barrett's Tumorigenesis.

Authors:  Joshua N Bernard; Vikram Chinnaiyan; Thomas Andl; Gregoire F Le Bras; M Nasar Qureshi; Deborah A Altomare; Claudia D Andl
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.